BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 12170185)

  • 1. Common prognostic factors for stage III melanoma patients and for stage I and II melanoma patients with recurrence to their regional lymph nodes.
    Konstadoulakis MM; Messaris E; Zografos G; Ricaniadis N; Androulakis G; Karakousis C
    Melanoma Res; 2002 Aug; 12(4):357-64. PubMed ID: 12170185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymph node ratio has impact on relapse and outcome in patients with stage III melanoma.
    Tas F; Erturk K
    Int J Clin Oncol; 2019 Jun; 24(6):721-726. PubMed ID: 30788673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of routine ilioinguinal lymph node dissection for palpable inguinal melanoma nodal metastasis.
    Glover AR; Allan CP; Wilkinson MJ; Strauss DC; Thomas JM; Hayes AJ
    Br J Surg; 2014 Jun; 101(7):811-9. PubMed ID: 24752717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant therapy of malignant melanoma and the role of sentinel node mapping.
    Eggermont AM
    Recent Results Cancer Res; 2000; 157():178-89. PubMed ID: 10857171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Axillary recurrence after lymph node excision in malignant melanoma].
    Kretschmer L; Lautenschläger C; Preusser KP; Fiedler H; Hetschko I
    Langenbecks Arch Chir; 1993; 378(1):4-11. PubMed ID: 8437502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term survival in 2,505 patients with melanoma with regional lymph node metastasis.
    White RR; Stanley WE; Johnson JL; Tyler DS; Seigler HF
    Ann Surg; 2002 Jun; 235(6):879-87. PubMed ID: 12035046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic variables for patients with stage III malignant melanoma.
    Messaris GE; Konstadoulakis MM; Ricaniadis N; Leandros E; Androulakis G; Karakousis PC
    Eur J Surg; 2000 Mar; 166(3):233-9. PubMed ID: 10755339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Number of Excised Lymph Nodes Has No Impact on Relapse and Survival in Patients With Stage III Melanoma.
    Tas F; Erturk K
    Ann Plast Surg; 2019 Oct; 83(4):455-458. PubMed ID: 31524742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment Outcome and Prognostic Factors for Malignant Skin Melanoma Treated with Radical Surgery.
    Majewski W; Stanienda K; Wicherska K; Ulczok R; Wydmanski J
    Asian Pac J Cancer Prev; 2015; 16(14):5709-14. PubMed ID: 26320440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for nodal recurrence after lymphadenectomy for melanoma.
    Pidhorecky I; Lee RJ; Proulx G; Kollmorgen DR; Jia C; Driscoll DL; Kraybill WG; Gibbs JF
    Ann Surg Oncol; 2001 Mar; 8(2):109-15. PubMed ID: 11258774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of sentinel lymph node biopsy in patients with local recurrence or in-transit metastasis of melanoma.
    Gipponi M; Solari N; Giovinazzo D; Queirolo P; Bertoglio S; Villa G; Gualco M; Bleidl D; Cafiero F
    Anticancer Res; 2014 Jun; 34(6):3197-203. PubMed ID: 24922694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Judging the therapeutic value of lymph node dissections for melanoma.
    Chan AD; Essner R; Wanek LA; Morton DL
    J Am Coll Surg; 2000 Jul; 191(1):16-22; discussion 22-3. PubMed ID: 10898179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.
    Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ
    Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elective lymph node dissection in stage I cutaneous malignant melanoma of the head and neck. A report from the Swedish Melanoma Study Group.
    Hansson J; Ringborg U; Lagerlöf B; Afzelius LE; Augustsson I; Blomquist E; Boeryd B; Carlin E; Edström S; Eldh J
    Melanoma Res; 1994 Dec; 4(6):407-11. PubMed ID: 7703722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nodal basin recurrence following lymph node dissection for melanoma: implications for adjuvant radiotherapy.
    Lee RJ; Gibbs JF; Proulx GM; Kollmorgen DR; Jia C; Kraybill WG
    Int J Radiat Oncol Biol Phys; 2000 Jan; 46(2):467-74. PubMed ID: 10661355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cutaneous malignant melanoma of the head and neck with intermediate tumor thickness: the role of elective lymph node dissection for clinical stage I].
    Wenzel S; Sagowski C; Neuber K; Kehrl W; Metternich FU
    Laryngorhinootologie; 2003 Jan; 82(1):19-24. PubMed ID: 12548460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prognosis of malignant melanoma following dissection regional lymph node metastases].
    Sprakel B; Stenschke F; Unnewehr M; Ladas A; Senninger N
    Chirurg; 2003 Jan; 74(1):55-60. PubMed ID: 12552406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognosis of patients with pathologic stage II cutaneous malignant melanoma.
    Roses DF; Provet JA; Harris MN; Gumport SL; Dubin N
    Ann Surg; 1985 Jan; 201(1):103-7. PubMed ID: 3966826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pelvic lymph node dissection is beneficial in subsets of patients with node-positive melanoma.
    Badgwell B; Xing Y; Gershenwald JE; Lee JE; Mansfield PF; Ross MI; Cormier JN
    Ann Surg Oncol; 2007 Oct; 14(10):2867-75. PubMed ID: 17671814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elective, therapeutic, and delayed lymph node dissection for malignant melanoma of the head and neck: analysis of 1444 patients from 1970 to 1998.
    Fisher SR
    Laryngoscope; 2002 Jan; 112(1):99-110. PubMed ID: 11802046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.